Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction.
暂无分享,去创建一个
D. Laskin | D. Heck | Y. Jan | J. Laskin | R. Casillas
[1] E. Weerapana,et al. Covalent protein modification: the current landscape of residue-specific electrophiles. , 2015, Current opinion in chemical biology.
[2] A. Miele,et al. Thioredoxin Reductase and its Inhibitors , 2014, Current protein & peptide science.
[3] D. Laskin,et al. Cross-linking of thioredoxin reductase by the sulfur mustard analogue mechlorethamine (methylbis(2-chloroethyl)amine) in human lung epithelial cells and rat lung: selective inhibition of disulfide reduction but not redox cycling. , 2014, Chemical research in toxicology.
[4] A. Holmgren,et al. The thioredoxin antioxidant system. , 2014, Free radical biology & medicine.
[5] C. Lillig,et al. Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. , 2013, Antioxidants & redox signaling.
[6] A. DeCaprio,et al. Covalent adduction of nitrogen mustards to model protein nucleophiles. , 2013, Chemical research in toxicology.
[7] Francisco J. Garcia,et al. Bifunctional electrophiles cross-link thioredoxins with redox relay partners in cells. , 2013, Chemical research in toxicology.
[8] A. Gow,et al. Attenuation of acute nitrogen mustard-induced lung injury, inflammation and fibrogenesis by a nitric oxide synthase inhibitor. , 2012, Toxicology and applied pharmacology.
[9] R. Begum,et al. Sulfur, oxygen, and nitrogen mustards: stability and reactivity. , 2012, Organic & biomolecular chemistry.
[10] A. Holmgren,et al. Thioredoxin system in cell death progression. , 2012, Antioxidants & redox signaling.
[11] W. Loke,et al. Sulfur mustard and respiratory diseases , 2012, Critical reviews in toxicology.
[12] A. Holmgren,et al. The role of thioredoxin in the regulation of cellular processes by S-nitrosylation. , 2012, Biochimica et biophysica acta.
[13] K. Fritz-Wolf,et al. Crystal structure of the human thioredoxin reductase-thioredoxin complex. , 2011, Nature communications.
[14] D. Laskin,et al. Sulfur mustard-induced pulmonary injury: therapeutic approaches to mitigating toxicity. , 2011, Pulmonary Pharmacology & Therapeutics.
[15] A. Gow,et al. Functional and inflammatory alterations in the lung following exposure of rats to nitrogen mustard. , 2011, Toxicology and applied pharmacology.
[16] D. Laskin,et al. Selective targeting of selenocysteine in thioredoxin reductase by the half mustard 2-chloroethyl ethyl sulfide in lung epithelial cells. , 2010, Chemical research in toxicology.
[17] N. Tretyakova,et al. Proteomic analysis of DNA-protein cross-linking by antitumor nitrogen mustards. , 2009, Chemical research in toxicology.
[18] R. Hartmann-Petersen,et al. Thioredoxin Txnl1/TRP32 Is a Redox-active Cofactor of the 26 S Proteasome* , 2009, Journal of Biological Chemistry.
[19] J. Yodoi,et al. Thioredoxin 1 delivery as new therapeutics. , 2009, Advanced drug delivery reviews.
[20] G. Di Trapani,et al. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy. , 2009, Molecular nutrition & food research.
[21] A. Holmgren,et al. Regulation of the Catalytic Activity and Structure of Human Thioredoxin 1 via Oxidation and S-Nitrosylation of Cysteine Residues* , 2008, Journal of Biological Chemistry.
[22] A. Holmgren,et al. Inhibition of the Human Thioredoxin System , 2008, Journal of Biological Chemistry.
[23] S. Muro,et al. Thioredoxin-1 Ameliorates Cigarette Smoke-Induced Lung Inflammation and Emphysema in Mice , 2008, Journal of Pharmacology and Experimental Therapeutics.
[24] Elias S. J. Arnér,et al. Cell Death by SecTRAPs: Thioredoxin Reductase as a Prooxidant Killer of Cells , 2008, PloS one.
[25] A. Holmgren,et al. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide , 2007, Proceedings of the National Academy of Sciences.
[26] K. Fritz-Wolf,et al. The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysis. , 2007, Journal of molecular biology.
[27] M. Ghanei,et al. Long Term Consequences from Exposure to Sulfur Mustard: A Review , 2007, Inhalation toxicology.
[28] Pedro A Fernandes,et al. Similarities and differences in the thioredoxin superfamily. , 2006, Progress in biophysics and molecular biology.
[29] Elias S. J. Arnér,et al. Selenocysteine in proteins-properties and biotechnological use. , 2005, Biochimica et biophysica acta.
[30] T. Sandström,et al. The nitrogen mustard melphalan activates mitogen‐activated phosphorylated kinases (MAPK), nuclear factor‐κB and inflammatory response in lung epithelial cells , 2005, Journal of applied toxicology : JAT.
[31] K. Becker,et al. The thioredoxin system—From science to clinic , 2004, Medicinal research reviews.
[32] J. Yodoi,et al. Redox-active protein thioredoxin prevents proinflammatory cytokine- or bleomycin-induced lung injury. , 2003, American journal of respiratory and critical care medicine.
[33] L. Herzenberg,et al. Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[34] Elias S. J. Arnér,et al. Physiological functions of thioredoxin and thioredoxin reductase. , 2000, European journal of biochemistry.
[35] A. Holmgren,et al. Essential Role of Selenium in the Catalytic Activities of Mammalian Thioredoxin Reductase Revealed by Characterization of Recombinant Enzymes with Selenocysteine Mutations* , 2000, The Journal of Biological Chemistry.
[36] R. Glockshuber,et al. Importance of Redox Potential for the in VivoFunction of the Cytoplasmic Disulfide Reductant Thioredoxin fromEscherichia coli * , 1999, The Journal of Biological Chemistry.
[37] C. Fenselau,et al. Covalent sequestration of the nitrogen mustard mechlorethamine by metallothionein. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[38] M. Kunkel,et al. Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides. , 1998, Biochemical pharmacology.
[39] N. Isowa,et al. Amelioration of ischemia-reperfusion injury by human thioredoxin in rabbit lung. , 1997, The Journal of thoracic and cardiovascular surgery.
[40] G. Powis,et al. Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer. , 1996, Structure.
[41] J. Dacre,et al. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. , 1995, Pharmacological reviews.
[42] S. Rink,et al. A mechlorethamine-induced DNA interstrand cross-link bends duplex DNA. , 1995, Biochemistry.
[43] A. Holmgren,et al. Determination of the reduction-oxidation potential of the thioredoxin-like domains of protein disulfide-isomerase from the equilibrium with glutathione and thioredoxin. , 1993, Biochemistry.
[44] A. Holmgren,et al. Rat liver thioredoxin and thioredoxin reductase: purification and characterization. , 1982, Biochemistry.